GTG (+ other sources): Viruses in pregnancy Flashcards

1
Q

What are the names of the virus responsible for chickenpox?

A

Varicella Zoster Virus/Human Herpes Virus 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What type of virus is VZV?

A

DNA virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the incubation period for VZV, Rubella, Parvovirus and Measles?

A

Parvovirus: 4-21 days
VZV: 7-21 days
Measles: 7-21 days
Rubella: 14-21 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When is the infectivity period for VZV, Rubella, Parvovirus and Measles?

A

Parvovirus: 10 days before to day of rash
Measles: 4 days before to 4 days after
Rubella: 7 days before to 10 days after
VZV: 2 days before until vesicles crusted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What percentage of the population is seropositive for VZV, Rubella, Parvovirus, Measles?

A

Parvovirus: 50-60%
Measles: >95%
Rubella: 93%
Chickenpox: >90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How frequently does primary infection with VZV occur in pregnancy?

A

3 in 1000 pregnancies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What type of vaccine VZV?

A

Live attenuated vaccine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How long does the immunity persist post VZV vaccination?

A

20 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How many doses of VZV vaccine and when?

A

2 doses 4-8 weeks apart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Effect of VZV vaccination

A

Reduces primary infection 80%

Reduces mortality 2/3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How long after vaccination should pregnancy be avoided for?

A

4 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Risks of varicella in pregnancy

A

Maternal risks:

  • Pneumonia
  • Hepatitis
  • Encephalitis
  • Death

Fetal varicella syndrome
Neonatal varicella infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What percentage of mothers with VZV with contract pneumonia?

A

5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mortality rate associated with VZV in pregnancy

A

0-14%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When does fetal varicella syndrome occur?

A

Patients who contracted varicella in first 28 weeks. Virus subsequently reactivates in utero.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How often does fetal varicella syndrome occur?

A

1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Features of fetal varicella syndrome

A

Dermatomal skin scarring
Eye defects (microphthalmia, chorioretinitis, cataracts)
Limb hypoplasia
Neurological abnormalities (microcephalic, Corsica atrophy, mental retardation, sphincter dysfunction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Risk of miscarriage with VZV

A

No increase in risk of first trimester miscarriage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

When does neonatal varicella infection occur?

A

When maternal infection occurs 1-4 weeks before delivery or immediately postpartum.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How is neonatal varicella infection contracted?

A

Transplacental, ascending vaginal or direct contact with lesions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What proportion of babies whose mothers develop VZV in the 4 weeks prior or immediate postpartum period will become infected?

A

50% infected.

23% clinical varicella.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Management of babies born within 7 days of mothers rash or where rash occurs within 7 days of birth.

A

Babies should have VZIG +/- aciclovir.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What constitutes a significant contact?

A

Same room for 15 minutes or more
Face-to-face contact
Contact in setting of large open ward

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Management of a pregnant woman who has a VZV contact?

A

If history of chickenpox - no further action required.
If uncertain history (or woman from tropical/subtropical country) - check booking sample for VZV IgG. If present - no further action.

If not immune then give VZIG if less than 10 days since contact (or for continuous exposure less than 10 days since appearance of rash in index case). Advise potentially infectious from 8-28 days after contact. Discuss postpartum varicella immunisation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Management of pregnant woman with chickenpox

A

If <24 hours since appearance of rash and >20+0 weeks pregnant, aciclovir 800mg 5 x per day for 7 days. Consider if <20 weeks. Avoid delivery of baby until at least 7 days after rash.
If <28 weeks then refer to FMU at 16-20 weeks or 5 weeks after the infection and consider amniocentesis to detect varicella DNA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Which pregnant women with chickenpox should be inpatients?

A

Severe disease - respiratory, neurological, haemorrhagic rash, bleeding.

IV Aciclovir.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

RIsk of anaphylaxis with VZIG

A

<0.1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Benefits of VZIG on fatal varicella syndrome

A

2.8% FVS if no VZIG, 0% if VZIG.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

When can you give a second dose of VZIG?

A

Further exposure reported and 3 weeks elapsed since last dose.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What is the positive predictive value for the presence of VZV antibodies in a patient with a history of chickenpox?

A

99%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What type of virus is CMV?

A

DNA virus (herpes virus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What percentage of pregnant population are seropositive for CMV?

A

Around 50%.

Within Asian population - 90%, White 45%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What percentage of pregnant women seroconvert for CMV in pregnancy?

A

1-7%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What percentage of live births are affected by CMV?

A

0.2-2.2%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What are the consequences of congenital CMV?

A

12% sensorineural hearing loss

8% of cerebral palsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Most common viral cause of congenital infection

A

CMV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Most common non-genetic cause of sensorineural hearing loss

A

CMV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What is the risk of congenital infection if mother has primary infection in pregnancy?

A

T1: 30%
T3: 47%
(But cases more severe and more likely to be detected antenatally in T1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What is the risk of congenital infection if mother has secondary infection (reactivation) in pregnancy?

A

1-2%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What percentage of infected infants with CMV will be symptomatic at birth?

A

13%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

What is the mortality rate associated with symptomatic congenital CMV?

A

30%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What proportion of infants who are asymptomatic at birth will go on to develop symptoms with CMV?

A

6-23%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

What percentage of women will be asymptomatic with a primary infection with CMV?

A

90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Who to suspect CMV seroconversion in?

A
  • Anyone with flu-like illness
  • Anyone with glandular fever and negative EBV serology
  • Anyone with hepatitis and negative hepatitis serology
  • Anyone with ultrasound features suggestive of CMV (only present in 25%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

How to test for maternal CMV?

A
  • Presence of IgG in previously seronegative individual
    OR
  • Presence of IgG and IgM of LOW avidity (<30%) suggests infection within last 3 months (>60% High avidity suggestive of infection more than 3 months ago or secondary infection)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

How to confirm fetal infection with CMV?

A

Amniocentesis for CMV DNA - must be after 20 weeks and 6-7 weeks since infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Incubation period of CMV

A

3-12 WEEKS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

What proportion of infants with congenital CMV are born to women with pre-existing immunity?

A

2/3

49
Q

Clinical features of congenital CMV at birth

A
Jaundice
Petechial rash
Hepatosplenomegaly
Microcephalic
SGA
50
Q

Treatment for maternal CMV

A

Nothing. Supportive.

51
Q

Treatment for congenital neonatal CMV

A

Vanganciclovir or ganciclovir within first 4 weeks of life.

52
Q

Management of neonate with suspected congenital CMV

A

Confirm diagnosis with urine or mouth swab for PCR within first 3 weeks of life

53
Q

Management of fetus with known CMV infection

A
  • Serial growth scans to include imaging of brain every 2-3 weeks
  • Fetal brain MRI 3-32 weeks
  • Consider fetal blood sample for platelet level

If severely symptomatic (USS brain abnormalities and low platelets) then prognosis poor)

54
Q

What type of virus is HSV?

A

DsDNA herpes virus

55
Q

What are the types of HSV?

A

Type 1 - usually oral herpes (responsible for 30% of genital infections)
Type 2 - usually genital herpes

56
Q

Prevalence of symptomatic HSV

A

37 per 100,000

57
Q

Incidence of neonatal herpes

A

1 in 60,000 births

58
Q

How to make diagnosis of primary HSV infection?

A

Swab lesion for viral PCR and compare type to maternal serology.

59
Q

Types of neonatal infection (HSV)

A
  • Localised (skin, eyes, mouth) - 30% of cases

- CNS or disseminated - 70% of cases

60
Q

Risks of localised infection (HSV)

A

Good prognosis

<2% risk of neurological/ocular morbidity

61
Q

Risks of CNS/dissemination infection (HSV)

A

CNS infection:

  • Mortality rate 6%
  • Neurological morbidity rate 70%

Disseminated infection:

  • Mortality rate 30%
  • Neurological morbidity rate 17%
62
Q

Effect of first trimester primary herpes

A

Nil fetal risks

Maternal risk of disseminated infection

63
Q

Management of primary HSV

A

Before 28 weeks - treat aciclovir and offer prophylaxis from 36 weeks (32 weeks if HIV positive)

After 28 weeks - treat Aciclovir and continue treatment until delivery.
Deliver via CS if within last 6 weeks of pregnancy.. If vaginal delivery then for neonatal aciclovir (20mg/kg TDS 10 days whilst awaiting result of lumbar puncture).

64
Q

Management of recurrent HSV

A

Acyclovir for any flare ups and then prophylactic from 36 weeks.

65
Q

Risk of neonatal herpes with recurrent HSV at time of delivery

A

1%

66
Q

Risk of neonatal herpes with primary HSV within 6 weeks prior to delivery

A

41%

67
Q

Recurrence rate of HSV infections

A

4 per year for HSV2
1 per year for HSV1
Recurrence rate reduces over time.

68
Q

Type of virus Zika virus

A

Flavivirus

SsRNA

69
Q

Vector for Zika virus transmission

A

Aedes Egypti mosquito

70
Q

Incubation period Zika virus

A

3-12 days

71
Q

Transmission methods of Zika virus

A
Primarily bite from aedes mosquito
Trans placental
Sexually transmitted
Blood transfusion
(Present in breast milk but no transmission confirmed via this route)
72
Q

How long is Zika virus detected in sperm for?

A

188 days but infectious only 69 days

73
Q

When is Zika virus mosquito Most active?

A

During daylight

74
Q

Prevention of Zika virus

A

Clothing
DEET
Mosquito nets

75
Q

Symptoms of Zika virus

A

Majority minimal symptoms. 2-7d short illness with rash, itching, fever, headache, arthralgia, myalgia, conjunctivitis, retro-orbital pain.

Can trigger Guillan Barre

76
Q

How long to avoid pregnancy for after travel to Zika virus country?

A

2 months if female partner.

3 months if male partner.

77
Q

What percentage does congenital Zia syndrome occur?

A

10%

78
Q

Features of congenital Zika syndrome?

A

FGR
Oligohydramnios
Talipes
Microcephalic, microopthalmia, cerebral calcification, ventriculomegaly, periventricular cysts, cerebellar atrophy, cysts,

79
Q

Investigation of a pregnant woman who has been to a Zika virus country

A

If she is symptomatic (or has been symptomatic within 2 weeks of return) then test serum for viral PCR and do baseline ultrasound. If infection confirmed or USS abnormalities then refer to FMU. If negative and confirmed on second sample then routine pregnancy care.

If she is asymptomatic then store serum and offer baseline USS and repeat at 18-20 weeks and consider at 30-32 weeks if normal. If USS abnormal then refer to FMU.

80
Q

Type of virus parvovirus

A

ssDNA

81
Q

What cells does parvovirus target?

A

Erythroid progenitor cells

82
Q

What does parvovirus cause?

A

Slapped cheek syndrome (erythema infectiosum or fifth disease)

83
Q

Percentage of adults with parvovirus infection who are asymptomatic

A

25-50%

84
Q

What age range is parvovirus most common in?

A

6-10 year olds

85
Q

What percentage of pregnancies are affected by parvovirus?

A

1 in 500

86
Q

What is the infectivity rate of parvovirus?

A

50%

87
Q

What is the risk of intrauterine infection with parvovirus at different gestations?

A

<4 weeks: 0%
4-16 weeks: 15%
>16 weeks: 25-70%

88
Q

What percentage of pregnancies exposed to parvovirus will develop non-immune hydrops?

A

3% of pregnancies exposed at < 20 weeks

89
Q

What is the mortality rate associated with parvovirus associated hydrops?

A

50%

90
Q

What is the average length of time between maternal infection and fetal symptoms in parvovirus?

A

6 weeks

91
Q

What is the fetal death rate associated with parvovirus?

A

9% if <20 weeks, <1% if >20 weeks

92
Q

What is mirror syndrome?

A

Rare condition which presents in late pregnancy with maternal oedema, hypertension, proteinuria and anaemia during conservative management of hydrops.

93
Q

How to make diagnosis of parvovirus in pregnancy?

A

Test IgM - if not detected, it excludes infection in the four weeks prior.
If present then confirm diagnosis by testing for viral DNA titre and looking at IgG on booking sample.

94
Q

What to do in someone exposed to parvovirus in pregnancy?

A

Test IgG and IgM.
If IgG positive and IgM negative - immune.
If both negative - susceptible.
If IgM positive - suspect infection.

95
Q

Management if parvovirus infection confirmed in pregnancy

A

Refer to FMU (to be seen within 4 weeks)
- Serial USS 4 weeks from symptoms/seroconversion

If suspected hydrops:

  • Amnio
  • Fetal blood sample and intrauterine RBC transfusion
96
Q

What benefit is seen from RBC transfusion in parvovirus infection?

A

Improves resolution from 5% to 55%

97
Q

At what gestation can a woman be reassured if no hydrops present when parvovirus contracted <20 weeks?

A

30 weeks

98
Q

Type of virus rubella

A

ssRNA

Togaviridae

99
Q

Infectivity risk with rubella

A

90%

100
Q

Percentage of people with rubella infection asymptomatic

A

50%

101
Q

Risk of intrauterine infection at different gestations with rubella infection

A

<11 weeks: 90%
11-16 weeks: 55%
>16 weeks: 45%

102
Q

Risk of adverse fetal outcome after rubella infection at different gestations

A

<11 weeks: 90%
11-16 weeks: 20 weeks
16-20 weeks: Mild deafness
>20 weeks: No risk

103
Q

Features of congenital rubella syndrome

A

Eye defects (cataracts)
Hearing impairment
Cardiac abnormalities (PDA and pulmonary artery stenosis)
CNS defects (microcephaly, mental and psychomotor retardation and progressive pancephalitis)
IUGR
Autism
Endocrine abnormalities (DM, thyroid)

104
Q

Risk of miscarriage after first trimester rubella infection

A

20%

105
Q

What to do if you suspect rubella in pregnancy?

A

Notifiable condition - contact health protection team who tell you how to test!

If positive - refer to FMU if <20 weeks and reassure if >20 weeks.

106
Q

What to do if contact with suspected rubella?

A

Contact local health protection team.

Conditions for immunity:
- 2 x documented vaccine doses
OR - 1 x antibody test

If not met immunity - test antibodies

107
Q

What to do if antibody tests show susceptible to rubella and has had contact?

A

Repeat 4 weeks

108
Q

For how long can infants with Congenital Rubella Syndrome transmit the virus?

A

Up to 1 year

109
Q

Mosquito responsible for malaria

A

Anopheles

110
Q

What is the most common type of malaria?

A

P. falciparum (80%, biggest burden in UK travellers, mostly West Africa)

111
Q

Risk of contracting malaria during 1 month stay without chemoprophylaxis in various continents:

A
Oceania: 1 in 20
Africa: 1 in 50
Asia/India: 1 in 500
South America: 1 in 2500
Central America/Caribbean: 1 in 10000
112
Q

Chemoprophylaxis in pregnancy for malaria

A

Mefloquine in 2nd/3rd trimesters (not if epileptic/neuropsychiatric disorders)
Chloroquine safe but may not be effective.
Malarone if chloroquine resistant and mefloquine CI.

113
Q

Definition of severe/complicated malaria

A

Parasitaemia >2% or severe clinical features

114
Q

What is Algid malaria?

A

Gram negative septicaemia secondary to malaria

115
Q

Mortality rate for uncomplicated and severe malaria

A

Uncomplicated 0.1%

Severe 15-20% non-pregnant, pregnant 50%

116
Q

Diagnosis of malaria

A

Blood film microscopy

117
Q

When can malaria be excluded in a febrile patient?

A

Three negative malaria smears 12-24h apart

118
Q

Treatment for malaria in pregnancy

A

Uncomplicated: Admit to hospital
Severe: Admit to ICU

Uncomplicated:

  • Falciparum: Quinine and clindamycin
  • Other: Chloroquine

Complicated:

  • IV Artesunate
  • IV Quinine
119
Q

Most common and important adverse effect of quinine

A

Hypoglycemia